TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Emerging Infectious Diseases
Study data from L. Boumgharbourtchai and co-authors update knowledge of emerging infectious diseases
September 16th, 2008
"Shigella sonnei UCN59, isolated during an outbreak of S. sonnei in January 2007, was resistant to azithromycin (MIC 64 mg/L)," investigators in Caen, France report. "The isolate contained a plasmid-borne mph(A) gene encoding a macrolide 2'-phosphotransferase that inactivates macrolides," wrote L. Boumgharbourtchai and colleagues. The researchers concluded: "Emergence of the mph(A) gene in S. sonnei may limit usefulness of azithromycin for treatment of shigellosis." Boumgharbourtchai and colleagues published their study in Emerging Infectious Diseases (Macrolide-resistant Shigella sonnei. Emerging Infectious...
Source: TB & Outbreaks Week (2008-09-16)
|
